Rapamycin reservoir eluting stent
Implantable medical devices may be utilized to locally delivery one or more drugs or therapeutic agents to treat a wide variety of conditions, including the treatment of the biological organism's reaction to the introduction of the implantable medical device. These therapeutic agents may be released under controlled and directional conditions from a stent so that the one or more therapeutic agents reach the correct target area, for example, the surrounding tissue.
1. A drug filled reservoir eluting implantable medical device comprising:
a stent comprising a helical mid section formed from a substantially sinusoidal arrangement of struts with alternating orientation configured to have a constant helical pitch connected via ductile hinges, the helical mid section comprising repeating strut strings that are geometrically self-symmetric, first and second ring end sections having a substantially sinusoidal arrangement of struts with alternating orientation connected via ductile hinges, and first and second transition zones in which there is no repeatability or geometric self-symmetry of the struts, the first and second transition zones having a variable pitch and formed from a substantially sinusoidal arrangement of struts with alternating orientation connected via ductile hinges, such that the first and second transition zones provide a gradual decrease in pitch between the helical mid section and the first and second ring end sections, the first and second ring end sections being connected to the helical mid section via the first and second helical transition sections respectively, wherein at least one of the struts comprise at least one reservoir; and a composition comprising an mTOR inhibitor and a biodegradable polymer, the composition being deposited in the at least one reservoir and configured to elute the mTOR inhibitor in the abluminal direction.
2. The drug filled reservoir eluting implantable medical device according to claim 1 , wherein the stent comprises a cobalt-chromium alloy.
3. The drug filled reservoir eluting Implantable medical device according to claim 2 , wherein the composition comprises rapamycin and poly(lactide-co-glycolide).
4. The drug filled reservoir eluting implantable medical device according to claim 3 , wherein the rapamycin comprises sirolimus.
5. The drug filled reservoir eluting implantable medical device according to claim 4 , further comprising a stabilizing agent.
6. The drug filled reservoir eluting implantable medical device according to claim 5 , wherein the stabilizing agent comprises butylated hydroxyl toluene.